Company intelligence / Profile preview
NanoSphere Health Sciences
- Ownership
- Private
- Development stage
- Other
Overview
NanoSphere Health Sciences has developed and commercialized the NanoSphere Delivery System, a phospholipid nanoparticle delivery platform for cannabinoids and other biologically active compounds. It has US and Canadian patents covering core nanoparticle manufacturing and a cannabinoid drug delivery system, and has launched transdermal cannabis products (Evolve Formulas NanoSerum) in Colorado with plans and agreements for broader US deployment and NSAID/nutraceutical pipelines.[2][4][6][7][9][10]
- Therapeutic areas
- PsychiatryImmunologyNeurologyGastroenterology
- Modalities
- NanoparticleDrug delivery technologyTransdermal formulationIntranasal formulationIntraoral formulation
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on NanoSphere Health Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanoSphere Health Sciences.